Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022)
Protagonist Therapeutics (PTGX) posted Exchange Rate Effect of $75000.0 for Q4 2022, up 142.86% sequentially from -$175000.0 in Q3 2022, and up 240.91% YoY from $22000.0 in Q4 2021.
Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022) Analysis & Trends
Protagonist Therapeutics has reported Exchange Rate Effect for 8 years, with the latest figure at $75000.0 in Q4 2022.
- Quarterly Exchange Rate Effect rose 240.91% year-over-year to $75000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$90000.0 (up 28.57% YoY) and the FY2022 annual result came in at -$90000.0, up 28.57% from the prior year.
- Exchange Rate Effect improved to $75000.0 in Q4 2022 per PTGX's latest filing, from -$175000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $123000.0 in Q3 2020 and troughed at -$175000.0 in Q3 2022.
- A 5-year average of -$14666.7 and a median of -$14000.0 in 2019 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 1244.44% in 2020, down 1000.0% in 2020.
- Over 5 years, Exchange Rate Effect stood at -$87000.0 in 2018, then sank by 43.68% to -$125000.0 in 2019, then jumped by 116.8% to $21000.0 in 2020, then rose by 4.76% to $22000.0 in 2021, then soared by 240.91% to $75000.0 in 2022.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $75000.0, -$175000.0, and -$19000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 75,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Sep 30, 2020 | 123,000.00 |
| Sep 30, 2020 | 123,000.00 |